2009Unpublished venueRequires access

Bipolar transurethral plasmakinetic prostatectomy for benign prostate hyperplasia(with the Report of 168 Cases)

Xuesong Chen, Xie Li-ren, Weibing Pan

Open publisher page 0 citations

Abstract

Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostatectomy (TUPKP) in the treatment of benign prostate hyperplasia(BPH). Methods Summarize the clinical data of 168 patients with BPH treated with TUPKP. Results The resected tissues weighed 32 ~ 102 g,averaging 58 g. The operation lasted 32~105 min,averaging 65 min. No transurethral resection syndrome(TURS) occurred. Followed up for 3~6 months,differences in IPSS scores(25. 8±2. 7vs5. 0±2. 7) (P <0. 05) ,QOL scores(5.2±0. 5vs2. 0 ±0. 3) (P <0. 05) ,the MFR(8. 4±2. 1 ml/s vs2.5. 7±2. 1 ml/s) (P <0. 05 ) ,the AFR(5.5±0. 6 ml/s vs12. 2±1.6 ml/s) (P <0. 05) ,the RU( 151.2±40. 0 ml vs25.2±13.2 ml) (P<0. 05)respectively. Conclusions TUPKP for the treatment of BPH is effective and safe with few complications and is worth promoting. Key words: Benign prostatic hyperplasia; bipolar plasmakinetic resection; transurethral prostatectomy

About this research paper

What this paper is about

Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostatectomy (TUPKP) in the treatment of benign prostate hyperplasia(BPH). Methods Summarize the clinical data of 168 patients with BPH treated with TUPKP. Results The resected tissues weighed 32 ~ 102 g,averaging 58 g. The operation lasted 32~105 min,averaging 65 min. No transurethral resection syndrome(TURS) occurred. Followed up for 3~6 months,differences in IPSS scores(25. 8±2. 7vs5. 0±2. 7) (P <0. 05) ,QOL scores(5.2±0. 5vs2. 0 ±0. 3) (P <0. 05) ,the MFR(8. 4±2. 1 ml/s vs2.5. 7±2. 1 ml/s) (P <0. 05 ) ,the AFR(5.5±0. 6 ml/s vs12. 2±1.6 ml/s) (P <0. 05) ,the RU( 151.2±40. 0 ml vs25.2±13.2 ml) (P<0. 05)respectively. Conclusions TUPKP for the treatment of BPH is effective and safe with few complications and is worth promoting. Key words: Benign prostatic hyperplasia; bipolar plasmakinetic resection; transurethral prostatectomy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostatectomy (TUPKP) in the treatment of benign prostate hyperplasia(BPH). Methods Summarize the clinical data of 168 patients with BPH treated with TUPKP. Results The resected tissues weighed 32 ~ 102 g,averaging 58 g. The operation lasted 32~105 min,averaging 65 min. No transurethral resection syndrome(TURS) occurred. Followed up for 3~6 months,differences in IPSS scores(25. 8±2. 7vs5. 0±2. 7) (P <0. 05) ,QOL scores(5.2±0. 5vs2. 0 ±0. 3) (P <0. 05) ,the MFR(8. 4±2. 1 ml/s vs2.5. 7±2. 1 ml/s) (P <0. 05 ) ,the AFR(5.5±0. 6 ml/s vs12. 2±1.6 ml/s) (P <0. 05) ,the RU( 151.2±40. 0 ml vs25.2±13.2 ml) (P<0. 05)respectively. Conclusions TUPKP for the treatment of BPH is effective and safe with few complications and is worth promoting. Key words: Benign prostatic hyperplasia; bipolar plasmakinetic resection; transurethral prostatectomy

Key concepts: Urology, Hyperplasia, Medicine, Prostatectomy, Prostate, Resection, Benign prostatic hyperplasia (BPH), Transurethral resection of the prostate

Related papers

Back to paper searchBrowse research topicsOriginal source
Bipolar transurethral plasmakinetic prostatectomy for benign prostate hyperplasia(with the Report of 168 Cases) — Research Paper | ScholarLens